Viewpoint Capital Management LLC Lowers Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Viewpoint Capital Management LLC lowered its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.0% in the 2nd quarter, Holdings Channel.com reports. The fund owned 4,874 shares of the company’s stock after selling 205 shares during the period. Viewpoint Capital Management LLC’s holdings in GE HealthCare Technologies were worth $361,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. NBC Securities Inc. purchased a new stake in shares of GE HealthCare Technologies in the first quarter worth $43,000. Merit Financial Group LLC raised its holdings in shares of GE HealthCare Technologies by 16.0% in the 1st quarter. Merit Financial Group LLC now owns 10,232 shares of the company’s stock valued at $826,000 after acquiring an additional 1,412 shares in the last quarter. Procyon Advisors LLC boosted its position in shares of GE HealthCare Technologies by 78.2% during the 1st quarter. Procyon Advisors LLC now owns 4,992 shares of the company’s stock valued at $403,000 after acquiring an additional 2,191 shares during the last quarter. Orrstown Financial Services Inc. purchased a new position in shares of GE HealthCare Technologies during the first quarter worth about $202,000. Finally, Wedmont Private Capital grew its holdings in shares of GE HealthCare Technologies by 7.0% during the first quarter. Wedmont Private Capital now owns 6,068 shares of the company’s stock worth $490,000 after purchasing an additional 395 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

GEHC opened at $76.41 on Tuesday. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The stock has a market capitalization of $34.89 billion, a PE ratio of 15.66, a price-to-earnings-growth ratio of 2.93 and a beta of 1.13. The stock’s 50 day moving average price is $74.22 and its 200-day moving average price is $72.44. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The company had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. During the same quarter in the previous year, the company earned $1.00 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of research analyst reports. BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Citigroup increased their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a research note on Thursday, July 31st. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research report on Thursday, September 18th. Finally, Zacks Research cut GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Seven investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $86.89.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.